Redx Pharma’s new Alderley Park-based immunology division is set to start work this month. The launch of Redx Immunology, which focuses on developing new therapies for immune system disorders, was officially announced on 14 May 2015. The division is expected to create 50 jobs over two years, mostly in high-tech scientific positions.
Dr Neil Murray, chief executive of Redx Pharma, said: “The immunology group is a little bit different because we’re building on our existing capabilities. It’s a logical next step for us. We’re not starting from scratch here so hopefully we’ll see developments coming through in the next 12 months or so.”
See the article in full at InsiderMedia.com